Shanghai Shen Lian Biomedical Corporation reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 137.85 million compared to CNY 152.44 million a year ago. Revenue was CNY 138.26 million compared to CNY 153.03 million a year ago.

Net income was CNY 23.28 million compared to CNY 44.42 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.11 a year ago. Diluted earnings per share from continuing operations was CNY 0.06 compared to CNY 0.11 a year ago.